Stryker Co. (NYSE:SYK) Shares Sold by Zhang Financial LLC

Zhang Financial LLC trimmed its holdings in shares of Stryker Co. (NYSE:SYK) by 1.2% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 75,301 shares of the medical technology company’s stock after selling 879 shares during the quarter. Stryker makes up approximately 1.9% of Zhang Financial LLC’s investment portfolio, making the stock its 13th largest position. Zhang Financial LLC’s holdings in Stryker were worth $22,549,000 as of its most recent SEC filing.

Several other large investors have also made changes to their positions in the business. Farmers & Merchants Trust Co of Chambersburg PA raised its stake in Stryker by 203.3% in the 4th quarter. Farmers & Merchants Trust Co of Chambersburg PA now owns 91 shares of the medical technology company’s stock valued at $27,000 after purchasing an additional 61 shares during the last quarter. Quarry LP acquired a new position in Stryker in the 1st quarter valued at $27,000. Freedom Wealth Alliance LLC acquired a new position in Stryker in the 4th quarter valued at $26,000. HBC Financial Services PLLC acquired a new position in Stryker in the 4th quarter valued at $37,000. Finally, Bourgeon Capital Management LLC acquired a new position in Stryker in the 4th quarter valued at $37,000. 77.09% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In other Stryker news, CAO William E. Berry, Jr. sold 7,690 shares of the business’s stock in a transaction on Thursday, March 7th. The stock was sold at an average price of $358.48, for a total transaction of $2,756,711.20. Following the sale, the chief accounting officer now directly owns 3,675 shares in the company, valued at $1,317,414. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. In related news, Director Ronda E. Stryker sold 201,146 shares of the stock in a transaction dated Monday, February 5th. The stock was sold at an average price of $342.90, for a total transaction of $68,972,963.40. Following the transaction, the director now directly owns 3,755,128 shares in the company, valued at $1,287,633,391.20. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CAO William E. Berry, Jr. sold 7,690 shares of the stock in a transaction dated Thursday, March 7th. The stock was sold at an average price of $358.48, for a total value of $2,756,711.20. Following the transaction, the chief accounting officer now owns 3,675 shares in the company, valued at $1,317,414. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 212,109 shares of company stock valued at $72,845,768. Company insiders own 5.90% of the company’s stock.

Analyst Upgrades and Downgrades

Several brokerages have issued reports on SYK. Royal Bank of Canada upped their target price on Stryker from $360.00 to $386.00 and gave the company an “outperform” rating in a report on Monday. TD Cowen upped their target price on Stryker from $365.00 to $400.00 and gave the company a “buy” rating in a report on Thursday, April 11th. StockNews.com upgraded Stryker from a “hold” rating to a “buy” rating in a report on Tuesday, January 23rd. Canaccord Genuity Group upgraded Stryker from a “hold” rating to a “buy” rating and set a $360.00 target price for the company in a report on Wednesday, January 31st. Finally, Canaccord Genuity Group upgraded Stryker from a “hold” rating to a “buy” rating and upped their target price for the company from $315.00 to $360.00 in a report on Wednesday, January 31st. Three research analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $340.45.

Stryker Stock Down 0.3 %

SYK stock traded down $1.14 during trading on Friday, hitting $326.31. 744,022 shares of the company’s stock were exchanged, compared to its average volume of 1,256,550. The business has a 50-day moving average price of $350.34 and a two-hundred day moving average price of $312.14. The stock has a market capitalization of $124.15 billion, a price-to-earnings ratio of 39.54, a PEG ratio of 2.71 and a beta of 0.89. Stryker Co. has a 52-week low of $249.98 and a 52-week high of $361.41. The company has a current ratio of 1.58, a quick ratio of 0.97 and a debt-to-equity ratio of 0.59.

Stryker (NYSE:SYK) last posted its earnings results on Tuesday, January 30th. The medical technology company reported $3.46 earnings per share for the quarter, topping the consensus estimate of $3.27 by $0.19. The firm had revenue of $5.82 billion during the quarter, compared to analysts’ expectations of $5.60 billion. Stryker had a return on equity of 22.99% and a net margin of 15.44%. The firm’s revenue was up 11.8% compared to the same quarter last year. During the same quarter in the previous year, the business earned $3.00 earnings per share. As a group, equities research analysts expect that Stryker Co. will post 11.86 EPS for the current year.

Stryker Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Tuesday, April 30th. Stockholders of record on Friday, March 29th will be issued a $0.80 dividend. This represents a $3.20 dividend on an annualized basis and a dividend yield of 0.98%. The ex-dividend date is Wednesday, March 27th. Stryker’s payout ratio is currently 38.79%.

Stryker Profile

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.